IMVT CLUSTER SEC Filing Analysis

Latest settled — T+20d

IMVT ▲ +10.80% at T+20d

NEUTRAL call ✓ call won +10.80% · α vs SPY +0.92% · entry $24.50 → $27.15

Next anchor: T+60d in 5w

Last close $34.15 (close May 22) · +39.39% from $24.50 entry

Entry anchored
Apr 1, 03:59 PM ET
via Databento tick

T+1d

+1.59%

call +1.59% · α +1.12%

$24.89

settled 7w ago

T+5d

0.00%

call 0.00% · α -3.62%

$24.50

settled 6w ago

T+20d

+10.80%

call +10.80% · α +0.92%

$27.15

settled 24d ago

T+60d

—

call — · α —

—

in 5w

Price Chart

Loading chart...

Executive Summary

Two Immunovant executives sold shares in open-market transactions totaling $522K, while multiple insiders received non-cash stock awards. The sales represent minimal market movement given the $5.2B market cap, and the grant activity is routine compensation.

Key Financial Metrics

Direction

selling

Total Value

$522.0K

Insiders

7

Actionable Insight

The level of selling is routine and not material enough to signal distress; traders should monitor for larger or more widespread dispositions. The stock award grants are standard and not a catalyst.

Key Facts

CEO Eric Venker sold 12,800 shares for $308K on April 2, 2026.
CTO Jay S. Stout sold 8,614 shares for $214K on April 8, 2026.
Multiple C-suite executives and directors received non-cash stock awards totaling millions in value, but these are not open-market transactions.
Total open-market selling volume: $522K, representing 0.01% of $5.2B market cap.
No insider buying occurred in the 7-day window.

Financial Impact

$522,000 in open-market sales (0.01% of market cap), no financial impact from non-cash grants

insider ownershipfloat

Risk Factors

Perception of insider selling could create short-term negative sentiment, despite immaterial volume.
Lack of insider buying may suggest limited confidence in near-term upside.

Market Snapshot

Exchange

Nasdaq

Sector

Biological Products, (No Diagnostic Substances)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

Document	Accession Number
CLUSTER Data (Synthetic)	cluster-IMVT-1775851401011

4 reports for IMVT

T+1T+5T+20T+60

Filters

Reports for IMVT — sortable, filterable
	Type				Now
May 20, 2026 3d ago	8-K MIXED ★ 6/10	$33.00 awaiting T+20	awaiting T+20	—	$34.15 (+3.48%)
May 20, 2026 3d ago	Press Release BULLISH ★ 7/10	$27.51 awaiting T+20	awaiting T+20	—	$34.15 (+24.14%)
Apr 23, 2026 4w ago	Insider Cluster NEUTRAL ★ 3/10	$28.91 $35.56	▲ +23.00%	▲ +18.37%	$34.15 (+18.13%)
Apr 2, 2026 7w ago	Insider Cluster NEUTRAL ★ 3/10	$24.50 $27.15	▲ +10.80%	▲ +0.92%	$34.15 (+39.39%)

US Market Status

Market Closed — Opens Tue (35h 14m)

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access